Trump Administration Limits COVID-19 Vaccine Access

The Donald Trump administration, through the United States — Food and Drug Administration, has unveiled a major new policy shift regarding COVID-19 vaccines. Annual shots for healthy younger adults and children will no longer be routinely approved. The United States — Food and Drug Administration will continue a streamlined approach for adults 65 and older, and younger adults/children with health problems, but urges companies to conduct large, lengthy studies for healthier individuals. This framework, published in the The New England Journal of Medicine, was co-authored by United States — Food and Drug Administration Commissioner Marty Makary and United States — Food and Drug Administration vaccine chief Vinay Prasad, who criticized the United States' 'one-size-fits-all' approach to boosters. Health Secretary Robert F. Kennedy Jr. has influenced this shift by appointing critics of previous COVID-19 vaccine recommendations to health agencies. Experts like Paul Offit express concerns that this policy could make vaccines less insurable and available, and that it appears to usurp the role of the United States — Centers for Disease Control and Prevention's advisory panel.